HNGE
Hinge Health, Inc.

724
Mkt Cap
$2.45B
Volume
738,911.00
52W High
$62.18
52W Low
$30.88
PE Ratio
-5.68
HNGE Fundamentals
Price
$32.01
Prev Close
$31.17
Open
$30.70
50D MA
$44.90
Beta
-0.47
Avg. Volume
899,998.90
EPS (Annual)
-$0.153
P/B
11.80
Loading...
Loading...
News
all
press releases
Hinge Health (NYSE:HNGE) Sets New 52-Week Low - Should You Sell?
Hinge Health (NYSE:HNGE) Sets New 1-Year Low - Here's What Happened...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Hinge Health (NYSE:HNGE) Sets New 1-Year Low - Here's Why
Hinge Health (NYSE:HNGE) Reaches New 52-Week Low - Here's What Happened...
MarketBeat·6d ago
News Placeholder
Hinge Health Inc. (NYSE:HNGE) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Hinge Health Inc. (NYSE:HNGE - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nineteen ratings firms that are currently covering the company...
MarketBeat·13d ago
News Placeholder
Hinge Healths 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care
Today, Hinge Health (NYSE: HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how todays fragmented healthcare system leaves many people unsure how to pursue...
Business Wire·25d ago
News Placeholder
Hinge Health (NYSE:HNGE) Trading Down 7.8% - Here's What Happened
Hinge Health (NYSE:HNGE) Stock Price Down 7.8% - Here's Why...
MarketBeat·26d ago
News Placeholder
Will Hinge Health Inc. (HNGE) Beat Estimates Again in Its Next Earnings Report?
Hinge Health Inc. (HNGE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·26d ago
News Placeholder
Hinge Health (NYSE:HNGE) CEO Sells $7,729,922.70 in Stock
Hinge Health Inc. (NYSE:HNGE - Get Free Report) CEO Daniel Antonio Perez sold 166,665 shares of the company's stock in a transaction on Monday, January 5th. The stock was sold at an average price of...
MarketBeat·1mo ago
News Placeholder
Hinge Health (NYSE:HNGE) Earns Buy Rating from Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and issued a $59.00 price objective on shares of Hinge Health in a research report on Tuesday...
MarketBeat·1mo ago
News Placeholder
Notable Newcomers: These 2025 IPOs Dominated the Year
Karman, Circle Internet, and Hinge Health were IPO winners in 2025. Their strong growth helped drive performance, and analysts see shares going even higher...
MarketBeat·1mo ago
News Placeholder
Hinge Health Inc. (NYSE:HNGE) Given Average Rating of "Moderate Buy" by Analysts
Hinge Health Inc. (NYSE:HNGE - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nineteen ratings firms that are covering the company, Marketbeat reports. One investment...
MarketBeat·1mo ago
<
1
2
...
>

Latest HNGE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.